Skip to content

FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)
Photo by: Michel Euler
FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)

Featured Photo Galleries

TYSON

The biggest villains in sports

Ray Rice is just the latest famous athlete to draw the ire of the American public. Sports stars haven’t always acted as role models — both on and off the field.